A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-Minichop) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)Konstantinos Christofyllakis,Viola Poeschel,Bettina Altmann,Stephanie Maurer,Vadim Lesan,Joerg Bittenbring,Igor Age Kos,Dominic Kaddu-Mulindwa,Zanir Abdi,Octavian Fleser,Sarah Altmeyer,Nina Rosa Neuendorff,Maike Nickelsen,Gerhard Held,Martin Dreyling,Florian Zettl,Christian Buske,Georg Lenz,Bertram Glass,Bjoern Chapuy,Norbert Schmitz,Theodoros Vassilakopoulos,German Ott,Reiner Siebert,Andreas Viardot,Florian Scherer,Roland Schmitz,Andreas Rosenwald,Dirk Hellwig,Markus Loeffler,Stephan Stilgenbauer,Lorenz Thurner,Moritz Bewarder,Marita ZiepertBLOOD（2023）引用 1|浏览46关键词Rituximab Therapy,RituximabAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
